SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell-mediated HIV transmission

FEBS Letters

Volumn 581, Issue 24, 2007, Pages 4596-4602

  Chang, Theresa L ^a   Teleshova, Natalia ^a   Rapista, Aprille ^a   Paluch, Maciej ^a   Anderson, Robert A ^b   Waller, Donald P ^c   Zaneveld, Lourens J D ^b   Granelli Piperno, Angela ^d   Klotman, Mary E ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Cell cell fusion; Dendritic cell; HIV transmission; Microbicide; Non sulfonated polyanions

Indexed keywords

ANTIGEN P24; GLYCOPROTEIN; MANDELIC ACID DERIVATIVE; POLYMER; SULFURIC ACID MODIFIED MANDELIC ACID; UNCLASSIFIED DRUG;

ARTICLE; CELL FUSION; CELL INTERACTION; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCUBATION TIME; INTERNALIZATION; PRIORITY JOURNAL; TARGET CELL; VIRUS TRANSMISSION;

CELLS, CULTURED; DENDRITIC CELLS; GLYCOPROTEINS; HIV INFECTIONS; HUMANS; MANDELIC ACIDS; POLYMERS; VIRAL PROTEINS; VIRUS INTERNALIZATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 34548666421     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.08.048     Document Type: Article

References (40)

1. Quinn T.C., and Overbaugh J. HIV/AIDS in women: an expanding epidemic. Science 308 (2005) 1582-15083
2. Simon V., Ho D.D., and Abdool Karim Q. HIV/AIDS epidemiology, pathogenesis, prevention, and treatment. Lancet 368 (2006) 489-504
3. Veazey R.S., et al. Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion. Nature 438 (2005) 99-102
4. Veazey R.S., et al. Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120. Nat. Med. 9 (2003) 343-346
5. Lederman M.M., et al. Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5. Science 306 (2004) 485-487
6. Pope M., and Haase A.T. Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Nat. Med. 9 (2003) 847-852
7. Hu J., Gardner M.B., and Miller C.J. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74 (2000) 6087-6095
8. Wu L., and KewalRamani V.N. Dendritic-cell interactions with HIV: infection and viral dissemination. Nat. Rev. Immunol. 6 (2006) 859-868
9. + T cells. Science 257 (1992) 383-387
10. Pope M., et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 78 (1994) 389-398
11. Pinchuk L.M., Polacino P.S., Agy M.B., Klaus S.J., and Clark E.A. The role of CD40 and CD80 accessory cell molecules in dendritic cell-dependent HIV-1 infection. Immunity 1 (1994) 317-325
12. Geijtenbeek T.B., et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100 (2000) 587-597
13. Lee B., et al. cis Expression of DC-SIGN allows for more efficient entry of human and simian immunodeficiency viruses via CD4 and a coreceptor. J. Virol. 75 (2001) 12028-12038
14. Turville S.G., et al. Immunodeficiency virus uptake, turnover, and 2-phase transfer in human dendritic cells. Blood 103 (2004) 2170-2179
15. Turville S.G., Cameron P.U., Handley A., Lin G., Pohlmann S., Doms R.W., and Cunningham A.L. Diversity of receptors binding HIV on dendritic cell subsets. Nat. Immunol. 3 (2002) 975-983
16. Gummuluru S., Rogel M., Stamatatos L., and Emerman M. Binding of human immunodeficiency virus type 1 to immature dendritic cells can occur independently of DC-SIGN and mannose binding C-type lectin receptors via a cholesterol-dependent pathway. J. Virol. 77 (2003) 12865-12874
17. Van Damme L., Chandeying V., Ramjee G., Rees H., Sirivongrangson P., Laga M., Perriens J., and COL-1492 Phase II Study Group. Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers. Aids 14 (2000) 85-88
18. Van Damme L., et al. Safety evaluation of nonoxynol-9 gel in women at low risk of HIV infection. Aids 12 (1998) 433-437
19. Van Damme L., et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 360 (2002) 971-977
20. Herold B.C., et al. Mandelic acid condensation polymer: novel candidate microbicide for prevention of human immunodeficiency virus and herpes simplex virus entry. J. Virol. 76 (2002) 11236-11244
21. Scordi-Bello I.A., et al. Candidate sulfonated and sulfated topical microbicides: comparison of anti-human immunodeficiency virus activities and mechanisms of action. Antimicrob. Agents Chemother. 49 (2005) 3607-3615
22. Zaneveld L.J., et al. Use of mandelic acid condensation polymer (SAMMA), a new antimicrobial contraceptive agent, for vaginal prophylaxis. Fertil. Steril. 78 (2002) 1107-1115
23. Galvin S.R., and Cohen M.S. The role of sexually transmitted diseases in HIV transmission. Nat. Rev. Microbiol. 2 (2004) 33-42
24. Plummer F.A. Heterosexual transmission of human immunodeficiency virus type 1 (HIV): interactions of conventional sexually transmitted diseases, hormonal contraception and HIV-1. AIDS Res. Hum. Retroviruses 14 Suppl. 1 (1998) S5-S10
25. Cohen M.S., et al., AIDSCAP Malawi Research Group. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HIV-1. Lancet 349 (1997) 1868-1873
26. Chesson H.W., and Pinkerton S.D. Sexually transmitted diseases and the increased risk for HIV transmission: implications for cost-effectiveness analyses of sexually transmitted disease prevention interventions. J. Acquir. Immune Defic. Syndr. 24 (2000) 48-56
27. Mabey D. Interactions between HIV infection and other sexually transmitted diseases. Trop. Med. Int. Health 5 (2000) A32-A36
28. Chang T.L., Vargas Jr. J., DelPortillo A., and Klotman M.E. Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. J. Clin. Invest. 115 (2005) 765-773
29. Chang T.L., Mosoian A., Pine R., Klotman M.E., and Moore J.P. A soluble factor(s) secreted from CD8(+) T lymphocytes inhibits human immunodeficiency virus type 1 replication through STAT1 activation. J. Virol. 76 (2002) 569-581
30. Trumpfheller C., Park C.G., Finke J., Steinman R.M., and Granelli-Piperno A. Cell type-dependent retention and transmission of HIV-1 by DC-SIGN. Int. Immunol. 15 (2003) 289-298
31. + cells. Nat. Med. 8 (2002) 150-156
32. Kwon D.S., Gregorio G., Bitton N., Hendrickson W.A., and Littman D.R. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 16 (2002) 135-144
33. Turville S.G., Arthos J., Donald K.M., Lynch G., Naif H., Clark G., Hart D., and Cunningham A.L. HIV gp120 receptors on human dendritic cells. Blood 98 (2001) 2482-2488
34. Curtis B.M., Scharnowske S., and Watson A.J. Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120. Proc. Natl. Acad. Sci. USA 89 (1992) 8356-8360
35. Boggiano C., Manel N., and Littman D.R. Dendritic cell-mediated trans-enhancement of human immunodeficiency virus type 1 infectivity is independent of DC-SIGN. J. Virol. 81 (2007) 2519-2523
36. McDonald D., Wu L., Bohks S.M., KewalRamani V.N., Unutmaz D., and Hope T.J. Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science 300 (2003) 1295-1297
37. Piguet V., and Sattentau Q. Dangerous liaisons at the virological synapse. J. Clin. Invest. 114 (2004) 605-610
38. Arrighi J.F., Pion M., Garcia E., Escola J.M., van Kooyk Y., Geijtenbeek T.B., and Piguet V. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells. J. Exp. Med. 200 (2004) 1279-1288
39. Ketas T.J., et al. Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cells. J. Virol. 77 (2003) 2762-2767
40. VanCompernolle S.E., et al. Antimicrobial peptides from amphibian skin potently inhibit human immunodeficiency virus infection and transfer of virus from dendritic cells to T cells. J. Virol. 79 (2005) 11598-11606